{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:35:01Z","timestamp":1781199301527,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1007\/bf01203288","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T12:17:53Z","timestamp":1109333873000},"page":"1-6","source":"Crossref","is-referenced-by-count":50,"title":["Punctal and canalicular stenosis associated with systemic fluorouracil therapy"],"prefix":"10.1007","volume":"90","author":[{"given":"H. M. A.","family":"Brink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. V. A. M","family":"Beex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"565","volume":"68","author":"JW Adams","year":"1984","unstructured":"Adams JW, Bofenkamp TM, Kobrin J, Wirtschafter JD, Zeese JA. Recurrent acute toxic optic neuropathy secondary to 5-FU. Cancer Treat Rep 1984; 68: 565?566.","journal-title":"Cancer Treat Rep"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0002-9394(77)90904-7","volume":"83","author":"WW Bixenman","year":"1977","unstructured":"Bixenman WW, Nicholls JVV, Warwick OH. Oculomotor disturbances associated with 5-fluorouracil chemotherapy. Am J Ophthalmol 1977; 83: 789?793.","journal-title":"Am J Ophthalmol"},{"key":"CR3","first-page":"247","volume":"6","author":"RH Blum","year":"1975","unstructured":"Blum RH. An overview of studies with adriamycin (NSC-123127) in the United States. Cancer Chemother Rep 1975; 6: 247?251.","journal-title":"Cancer Chemother Rep"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archopht.1981.03930010286013","volume":"99","author":"LP Caravella Jr","year":"1981","unstructured":"Caravella LP Jr, Burns JA, Zangmeister M. Punctal-canalicular stenosis related to systemic fluorouracil therapy. Arch Ophthalmol 1981; 99: 284?286.","journal-title":"Arch Ophthalmol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-89-4-574_1","volume":"89","author":"N Christophidis","year":"1978","unstructured":"Christophidis N, Lucas I, Vajda FJE, Louis WJ. Lacrimation and 5-fluorouracil. Ann Intern Med 1978; 89: 574.","journal-title":"Ann Intern Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0002-9394(89)90853-2","volume":"108","author":"The Fluorouracil Filtering Surgery Study Group","year":"1989","unstructured":"The Fluorouracil Filtering Surgery Study Group. Fluorouracil filtering surgery study one-year follow-up. Am J Ophthalmol 1989; 108: 625?635.","journal-title":"Am J Ophthalmol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-6420(83)34600-5","volume":"90","author":"FT Fraunfelder","year":"1983","unstructured":"Fraunfelder FT, Meyer SM. Ocular toxicity of antineoplastic agents. Ophthalmology 1983; 90: 1?3.","journal-title":"Ophthalmology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/1097-0142(19811001)48:7<1539::AID-CNCR2820480713>3.0.CO;2-B","volume":"48","author":"JD Griffin","year":"1981","unstructured":"Griffin JD, Garnick MB. Eye toxicity of cancer chemotherapy: a review of the literature. Cancer 1981; 48: 1539?1549.","journal-title":"Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-88-5-657_1","volume":"88","author":"DJ Haidak","year":"1978","unstructured":"Haidak DJ, Hurwitz BS, Yeung KY. Tear-duct fibrosis (dacryostenosis) due to 5-fluorouracil. Ann Intern Med 1978; 88: 657.","journal-title":"Ann Intern Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jama.1973.03220340051021","volume":"225","author":"J Hamersley","year":"1973","unstructured":"Hamersley J, Luce JK, Florentz TR, Burkholder MM, Pepper JJ. Excessive lacrimation from flurouracil treatment. JAMA 1973; 225: 747?748.","journal-title":"JAMA"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archderm.1978.01640220047012","volume":"114","author":"T Horio","year":"1978","unstructured":"Horio T, Murai T, Ikai K. Photosensitivity due to a fluorouracil derivate. Arch Dermatol 1978; 114: 1498?1500.","journal-title":"Arch Dermatol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0039-6257(89)90105-7","volume":"34","author":"PS Imperia","year":"1989","unstructured":"Imperia PS, Lazarus HM, Lass JH. Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 1989; 34: 209?230.","journal-title":"Surv Ophthalmol"},{"key":"CR13","first-page":"374","volume":"19","author":"MS Insler","year":"1987","unstructured":"Insler MS, Helm CJ. Ankyloblepharon associated with systemic 5-fluorouracil treatment. Ann Ophthalmol 1987; 19: 374?375.","journal-title":"Ann Ophthalmol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9394(14)74224-2","volume":"103","author":"A Knapp","year":"1987","unstructured":"Knapp A, Heuer DK, Stern GA, Driebe WT. Serious corneal complications of glaucoma filtering surgery with postoperative 5-fluorouracil. Am J Ophthalmol 1987; 103: 183?187.","journal-title":"Am J Ophthalmol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/07357909009012068","volume":"8","author":"CL Loprinzi","year":"1990","unstructured":"Loprinzi CL, Love RR, Garrity JA, Ames MM. Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity. Cancer Investigation 1990; 8: 459?465.","journal-title":"Cancer Investigation"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9394(84)90391-X","volume":"97","author":"L Salminen","year":"1984","unstructured":"Salminen L, Jantti V, Bronross M. Blepharospasm associated with tegafur combination chemotherapy. Am J Ophthalmol 1984; 97: 649?650.","journal-title":"Am J Ophthalmol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/1097-0142(19851015)56:8<2148::AID-CNCR2820560845>3.0.CO;2-R","volume":"56","author":"SR Seiff","year":"1985","unstructured":"Seiff SR, Shorr N, Adams T. Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy. Cancer 1985; 56: 2148?2149.","journal-title":"Cancer"},{"key":"CR18","first-page":"580","volume":"26","author":"MS Shapiro","year":"1985","unstructured":"Shapiro MS, Thoft RA, Friend J, Parrish RK, Gressel MG. 5-Fluorouracil toxicity to the ocular surface epithelium. Invest Ophthalmol Vis Sci 1985; 26: 580?583.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mpo.2950030104","volume":"3","author":"DJ Straus","year":"1977","unstructured":"Straus DJ, Mausolf FA, Ellerby RA, McCracken JD. Cicatricial ectropion secondary to 5-fluorouracil therapy. Med Pediatr Oncol 1977; 3: 15?19.","journal-title":"Med Pediatr Oncol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/1097-0142(19820515)49:10<1999::AID-CNCR2820491009>3.0.CO;2-B","volume":"49","author":"M Vizel","year":"1982","unstructured":"Vizel M, Oster MW. Ocular side effects of cancer chemotherapy. Cancer 1982; 49: 1999?2002.","journal-title":"Cancer"},{"key":"CR21","first-page":"7734","volume":"55","author":"AJ Weiss","year":"1961","unstructured":"Weiss AJ, Jackson LG, Carabisi R. An evaluation of 5-fluorouracil in malignant disease. Ann Intern Med 1961; 55: 7734?7741.","journal-title":"Ann Intern Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM197407112910205","volume":"291","author":"HD Weiss","year":"1974","unstructured":"Weiss HD, Walker MD, Wierni PH. Neurotoxicity of commonly used antineoplastic agents. N Eng J Med 1974; 291: 75?81.","journal-title":"N Eng J Med"},{"key":"CR23","first-page":"1919","volume":"129","author":"MJW Zaal","year":"1985","unstructured":"Zaal MJW, Polak BCP. Oogheelkundige bijwerkingen van het gebruik van cytostatica. Ned Tijdschr Geneeskd 1985; 129: 1919?1921.","journal-title":"Ned Tijdschr Geneeskd"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01203288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01203288\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01203288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T13:01:57Z","timestamp":1556715717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01203288"}},"subtitle":["Report of five cases and review of the literature"],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["BF01203288"],"URL":"https:\/\/doi.org\/10.1007\/bf01203288","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}